Eli Glezer
Founder chez SINGULAR GENOMICS SYSTEMS, INC.
Fortune : 2 M $ au 31/03/2024
Profil
Dr. Eli Glezer is a Chief Scientific Officer at Singular Genomics Systems, Inc. Dr. Glezer was previously employed as a Chief Technology Officer by Meso Scale Diagnostics LLC.
He received his undergraduate degree from the University of California, Berkeley and a doctorate degree from Harvard University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/03/2024 | 4 585 000 ( 6,20% ) | 2 M $ | 31/03/2024 |
Postes actifs de Eli Glezer
| Sociétés | Poste | Début |
|---|---|---|
| SINGULAR GENOMICS SYSTEMS, INC. | Founder | 01/06/2016 |
Anciens postes connus de Eli Glezer
| Sociétés | Poste | Fin |
|---|---|---|
Meso Scale Diagnostics LLC
 Meso Scale Diagnostics LLC Medical SpecialtiesHealth Technology Meso Scale Diagnostics LLC develops and markets solutions for multiplex biological assays. Its products include angiogenesis and vascular, bone metabolism, cytokine and chemokine, inflammation, intracellular signaling, neurodegeneration, toxicology, and immuno assay kits. The firms services include assay development, custom conjugation, prototype printing, instrument services and warranties. The company was founded in 1995 and is headquartered in Rockville, MD. | Chief Tech/Sci/R&D Officer | 01/01/2016 |
Formation de Eli Glezer
| Harvard University | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SINGULAR GENOMICS SYSTEMS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Meso Scale Diagnostics LLC
Meso Scale Diagnostics LLC Medical SpecialtiesHealth Technology Meso Scale Diagnostics LLC develops and markets solutions for multiplex biological assays. Its products include angiogenesis and vascular, bone metabolism, cytokine and chemokine, inflammation, intracellular signaling, neurodegeneration, toxicology, and immuno assay kits. The firms services include assay development, custom conjugation, prototype printing, instrument services and warranties. The company was founded in 1995 and is headquartered in Rockville, MD. | Health Technology |
